John King Selected Research

John King Research Topics

Disease

7	Multiple Sclerosis 11/2014 - 05/2007
4	Tendinopathy (Tendonitis) 04/2014 - 01/2008
3	Relapsing-Remitting Multiple Sclerosis 08/2011 - 05/2003
3	Infections 09/2007 - 07/2003
2	Wounds and Injuries (Trauma) 01/2020 - 03/2006
2	Pain (Aches) 01/2017 - 05/2002
2	Schizophrenia (Dementia Praecox) 01/2014 - 01/2013
1	Neoplasms (Cancer) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Neuromyelitis Optica (Devic's Disease) 05/2020
1	Inflammation (Inflammations) 05/2020
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020
1	Epilepsy (Aura) 01/2019
1	Toxoplasmosis 10/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2017
1	Hypoxia (Hypoxemia) 01/2016
1	Lymphoma (Lymphomas) 06/2014
1	Atrophy 07/2013
1	Craniocerebral Trauma (Head Injury) 05/2013
1	Atrial Fibrillation 05/2013
1	Multiple Fractures 05/2013
1	Progressive Multifocal Leukoencephalopathy 08/2011
1	Vasculitis (Vasculitides) 09/2007
1	Retinitis 09/2007
1	Retinal Neovascularization 09/2007
1	Edema (Dropsy) 09/2007
1	Disease Progression 09/2007
1	Vitreous Hemorrhage 09/2007
1	Acute Retinal Necrosis Syndrome 09/2007
1	Opportunistic Infections (Opportunistic Infection) 05/2007
1	Human Influenza (Influenza) 01/2007
1	Myasthenia Gravis 12/2003
1	Respiratory Insufficiency (Respiratory Failure) 06/2003
1	Hepatitis C 02/2003
1	Chronic Hepatitis C 02/2003

Drug/Important Bio-Agent (IBA)

3	Natalizumab (Tysabri)FDA Link 06/2014 - 05/2007
3	InterferonsIBA 06/2007 - 02/2003
2	ethyleneIBA 01/2016 - 06/2007
1	Pharmaceutical PreparationsIBA 01/2022
1	AutoantibodiesIBA 05/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Irritants (Vesicants)IBA 01/2017
1	ChlorophyllIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	Cysteine (L-Cysteine)FDA Link 01/2016
1	Ketamine FDA LinkGeneric 01/2014
1	Glatiramer Acetate (Copaxone)FDA Link 07/2013
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2013
1	Retinaldehyde (Retinal)IBA 09/2007
1	Acyclovir (Aciclovir)FDA LinkGeneric 09/2007
1	Foscarnet FDA LinkGeneric 09/2007
1	Betaine (C.B.B.)FDA Link 06/2007
1	caffeate O-methyltransferaseIBA 06/2007
1	1-aminocyclopropane-1-carboxylic acid oxidaseIBA 06/2007
1	nicotianamineIBA 06/2007
1	nicotianamine synthaseIBA 06/2007
1	phosphorylethanolamine (phosphoethanolamine)IBA 06/2007
1	HydrolasesIBA 06/2007
1	LigninIBA 06/2007
1	Methionine AdenosyltransferaseIBA 06/2007
1	MethyltransferasesIBA 06/2007
1	Oxidoreductases (Dehydrogenase)IBA 06/2007
1	PolyaminesIBA 06/2007
1	Messenger RNA (mRNA)IBA 06/2007
1	Adenosylmethionine DecarboxylaseIBA 06/2007
1	5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)IBA 06/2007
1	Neutralizing AntibodiesIBA 06/2007
1	VaccinesIBA 01/2007
1	terpene synthaseIBA 03/2006
1	Prednisolone (Predate)FDA LinkGeneric 12/2003
1	Azathioprine (Imuran)FDA LinkGeneric 12/2003
1	Interferon-alpha (Interferon Alfa)IBA 02/2003
1	Ribavirin (Virazole)FDA LinkGeneric 02/2003

Therapy/Procedure

5	Therapeutics 01/2022 - 11/2014
4	Injections 04/2014 - 01/2008
2	Length of Stay 05/2013 - 06/2003
1	Surgical Instruments (Clip) 01/2020
1	Anterior Temporal Lobectomy 01/2019
1	Prolotherapy 01/2017
1	Aftercare (After-Treatment) 06/2014
1	Treatment Delay 07/2013
1	Conservative Treatment 01/2008
1	Vitrectomy 09/2007
1	Chemoprevention 01/2007
1	Hand Hygiene 01/2007
1	N95 Respirators 01/2007
1	Thymectomy 12/2003
1	Immunotherapy 12/2003
1	Nutritional Support (Artificial Feeding) 07/2003
1	Postoperative Care 07/2003
1	Sympathectomy (Sympathectomies) 05/2002